|1.||Okunieff, Paul: 2 articles (03/2015 - 07/2006)|
|2.||Xiao, Zhenyu: 2 articles (01/2010 - 07/2006)|
|3.||Fueth, Matthias: 1 article (03/2015)|
|4.||Wei, Fenghuan: 1 article (03/2015)|
|5.||Singh, Ravi Shankar Prasad: 1 article (03/2015)|
|6.||Derendorf, Hartmut: 1 article (03/2015)|
|7.||Swarts, Steven: 1 article (03/2015)|
|8.||Ci, Xinxin: 1 article (01/2015)|
|9.||Li, Dan: 1 article (01/2015)|
|10.||Ren, Hua: 1 article (01/2015)|
01/01/2015 - "Esculentoside A Attenuates Allergic Airway Inflammation via Activation of the Nrf-2 Pathway."
06/01/2004 - "To investigate the influence of esculentoside A (EsA) on immunological function and its mechanism of anti-inflammation. "
03/25/2015 - "Phytolcaccagenin has anti-inflammatory activities that exceed those of Esculentoside A and its derivatives regarding suppression of LPS-induced inflammation, and has a lower toxicity profile with less hemolysis. "
01/01/2010 - "Esculentoside A (EsA), a saponin isolated from the root of Phytolacca esculenta, has been reported to exert anti-inflammatory effects in several animal models of acute and chronic inflammation by inhibiting the production and activity of pro-inflammatory cytokines in macrophages and epithelial cells. "
|3.||Acute Lung Injury